The additions included companies that are customers of Intel and Nvidia, and one firm that was the focus of a New York Times ...
DeepSeek briefly crashed Nvidia’s stock because of speculation that its models require far fewer chips. Now, Chinese fintech ...
The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.